Patents by Inventor Marion MOUTON

Marion MOUTON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Broad range gene and genotype papillomavirus transcriptome as a biomarker of papillomavirus-associated cancer stages
    Patent number: 11530452
    Abstract: The present invention provides compositions, kits, and method for determining the levels of expression of human polyoma or papillomavirus species and RNA transcripts. These levels can be used for the prognosis of risk of developing virally-induced cancers. The ratio (R) between early and late transcripts is indicative of HPV infections associated with higher risk of developing genital neoplasia and cancer.
    Type: Grant
    Filed: September 3, 2020
    Date of Patent: December 20, 2022
    Assignees: INSTITUT PASTEUR, ECOLE NATIONALE VETERINAIRE D'ALFORT, PATHOQUEST, L'ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS
    Inventors: Marc Eloit, Nicolas Torno, Jean Deregnaucourt, Marion Mouton, Isabelle Heard, Philippe Perot
  • BROAD RANGE GENE AND GENOTYPE PAPILLOMAVIRUS TRANSCRIPTOME AS A BIOMARKER OF PAPILLOMAVIRUS-ASSOCIATED CANCER STAGES
    Publication number: 20210032705
    Abstract: The present invention provides compositions, kits, and method for determining the levels of expression of human polyoma or papillomavirus species and RNA transcripts. These levels can be used for the prognosis of risk of developing virally-induced cancers. The ratio (R) between early and late transcripts is indicative of HPV infections associated with higher risk of developing genital neoplasia and cancer.
    Type: Application
    Filed: September 3, 2020
    Publication date: February 4, 2021
    Inventors: Marc ELOIT, Nicolas TORNO, Jean DEREGNAUCOURT, Marion MOUTON, Isabelle HEARD, Philippe PEROT
  • Broad range gene and genotype papillomavirus transcriptome as a biomarker of papillomavirus-associated cancer stages
    Patent number: 10808284
    Abstract: The present invention provides compositions, kits, and method for determining the levels of expression of human polyoma or papillomavirus species and RNA transcripts. These levels can be used for the prognosis of risk of developing virally-induced cancers. The ratio (R) between early and late transcripts is indicative of HPV infections associated with higher risk of developing genital neoplasia and cancer.
    Type: Grant
    Filed: July 7, 2015
    Date of Patent: October 20, 2020
    Assignees: INSTITUT PASTEUR, ECOLE NATIONALE VETERINAIRE D'ALFORT, PATHQUEST, L'ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS
    Inventors: Marc Eloit, Nicolas Torno, Jean Deregnaucourt, Marion Mouton, Isabelle Heard, Philippe Perot
  • BROAD RANGE GENE AND GENOTYPE PAPILLOMAVIRUS TRANSCRIPTOME AS A BIOMARKER OF PAPILLOMAVIRUS-ASSOCIATED CANCER STAGES
    Publication number: 20170107582
    Abstract: The present invention provides compositions, kits, and method for determining the levels of expression of human polyoma or papillomavirus species and RNA transcripts. These levels can be used for the prognosis of risk of developing virally-induced cancers. The ratio (R) between early and late transcripts is indicative of HPV infections associated with higher risk of developing genital neoplasia and cancer.
    Type: Application
    Filed: July 7, 2015
    Publication date: April 20, 2017
    Inventors: Marc ELOIT, Nicolas TORNO, Jean DEREGNAUCOURT, Marion MOUTON, Isabelle HEARD, Philippe PEROT